Thus, we postulated that VARS2 alterations may contribute to non-ischemic cardiomyopathies or influence patients’ clinical courses and outcomes, and we aimed to investigate the possible disease mechanisms. Here, VARS2 is linked to ischemic cardiomyopathy.